MGT Capital Investments, Inc. Comments on Recent Price Movement in Its Common Stock
NEW YORK--(BUSINESS WIRE)--
MGT Capital Investments, Inc. ("MGT or the "Company") (NYSE Amex:
MGT.BC) said today that there have been no material undisclosed
developments which would account for the recent increase in the price of
its common stock. The Company was notified today by the NYSE Amex of
unusual trading activity in its stock. The NYSE Amex requested the
Company to respond by press release to the unusual activity. The
Company's general policy is not to comment on market rumors or
speculation including unusual market activity and instead urges
investors to look to the Company's filings with the SEC and its official
About MGT Capital Investments, Inc.
MGT is a holding company comprised of MGT, the parent company, and its
wholly-owned subsidiary MGT Capital Investments (U.K.) Limited. In
addition we also have a controlling interest in our subsidiary,
Medicsight Ltd, including its wholly owned subsidiaries.
Medicsight is a medical technology company with operations in medical
imaging software development and medical hardware devices. The company
provides a computer-aided detection software application that is used to
assist radiologists with early detection and measurement of colorectal
polyps. The company's software received a CE Mark in 2009, as well as
clearance from the U. S. FDA in May 2011. Medicsight has also developed
an automated carbon dioxide medical inflation device and associated
disposable tubing (MedicCO 2 LON) that is being commercialized in
partnership with a global distributor.
MGT Capital Investments, Inc.
Robert Ladd, 914-630-7430
and Chief Executive Officer
Chief Financial Officer
Source: MGT Capital Investments, Inc.
News Provided by Acquire Media